Healthcare -
Biotechnology - NASDAQ - US
$ 2.46
-0.806 %
$ 85 M
Market Cap
-2.62
P/E
GNLX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities GNLX - Genelux Corporation
44 M
LAST VALUE
1184.67%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR